Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-23-009635

Options or other derivatives

  • Chief Scientific Officer acquired 1,400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Brake Rachael Louise · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-13 Grant or award : show line 1 in the form Stock Option (right to buy) +1,400,000 1,400,000 D
Loading xslF345X03/doc4.xml…